Cogent Biosciences, Inc.·4

Jan 4, 4:20 PM ET

Ros Matthew 4

4 · Cogent Biosciences, Inc. · Filed Jan 4, 2024

Insider Transaction Report

Form 4
Period: 2024-01-02
Ros Matthew
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-01-02+3,0513,051 total
    Exercise: $6.24From: 2024-01-02Exp: 2034-01-02Common Stock (3,051 underlying)
Footnotes (1)
  • [F1]The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4